DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Bielekova B, Richert N, Howard T et al.
Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon beta.
Proc Natl Acad Sci U S A 2004;
101: 8705-8708
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.